Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biohit Oyj Updates on Establishment of Chinese Joint Venture


Wednesday, 13 Nov 2013 04:00am EST 

Biohit Oyj announced that the official Certificate of Approval required for the establishment of a Joint Venture with foreign investment in the People‚Äôs Republic of China has been received for the Joint Venture formed between Anhui Wisdom-win Investment Co, Ltd. and Biohit Oyj. The Joint Venture has been registered as Biohit Healthcare (Hefei) Co., Ltd., located in the city of Hefei in Anhui province, China. The regulatory approvals regarding the start of the production are pending and are expected to be finalized during 2014. 

Company Quote

4.71
0.03 +0.64%
23 Dec 2014